NASDAQ:XBIT
XBiotech Inc.
XBiotech Inc. reported net income of −$45.5M in fiscal 2025. Free cash flow was −$40.2M.Summary generated from XBiotech Inc.'s SEC filings. Latest annual report filed Mar 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−28.2%
Debt / equityn/a
Free cash flow−$40.2M
FCF marginn/a
Share count change+0.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 18 | 4 | 0 | n/a | n/a |
| Operating income | −25 | −34 | −38 | −42 | −56 |
| Net income | −17 | −33 | −25 | −39 | −46 |
| Free cash flow | 66 | −15 | −19 | −32 | −40 |
Recent filings
- DEF 14AProxy statement
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 14, 2026 - 10-K/AAmended annual report for the fiscal year ended Dec 31, 2025
Apr 29, 2026 - 10-KAnnual report for the fiscal year ended Dec 31, 2025
Mar 13, 2026 - 8-KDirector or officer change
Dec 9, 2025 - 10-QQuarterly report for the period ended Sep 30, 2025
Nov 12, 2025 - 4Insider transaction report
Nov 12, 2025